<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36543790</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Molecular mechanism of antibody neutralization of coxsackievirus A16.</ArticleTitle><Pagination><StartPage>7854</StartPage><MedlinePgn>7854</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7854</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-35575-w</ELocationID><Abstract><AbstractText>Coxsackievirus A16 (CVA16) causes hand, foot and mouth disease in infants and young children. However, no vaccine or anti-viral agent is currently available for CVA16. Here, the functions and working mechanisms of two CVA16-specific neutralizing monoclonal antibodies (MAbs), 9B5 and 8C4, are comprehensively investigated. Both 9B5 and 8C4 display potent neutralization in vitro and prophylactic and therapeutic efficacy in a mouse model of CVA16 infection. Mechanistically, 9B5 exerts neutralization primarily through inhibiting CVA16 attachment to cell surface via blockade of CVA16 binding to its attachment receptor, heparan sulfate, whereas 8C4 functions mainly at the post-attachment stage of CVA16 entry by interfering with the interaction between CVA16 and its uncoating receptor SCARB2. Cryo-EM studies show that 9B5 and 8C4 target distinct epitopes located at the 5-fold and 3-fold protrusions of CVA16 capsids, respectively, and exhibit differential binding preference to three forms of naturally occurring CVA16 particles. Moreover, 9B5 and 8C4 are compatible in formulating an antibody cocktail which displays the ability to prevent virus escape seen with individual MAbs. Together, our work elucidates the functional and structural basis of CVA16 antibody-mediated neutralization and protection, providing important information for design and development of effective CVA16 vaccines and antibody therapies.</AbstractText><CopyrightInformation>Â© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8658-9009</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Caixuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yalei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Xiaohua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qingwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Yannan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7164-8694</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China. cong@sibcb.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2161-1359</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Molecular Virology &amp; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China. huangzhong@ips.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. huangzhong@ips.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Z.H., J.S. and C.Z. are listed as inventors on pending patent applications for the MAbs. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36543790</ArticleId><ArticleId IdType="pmc">PMC9769477</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-35575-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-35575-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Poyry T, et al. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology. 1994;202:982â987. doi: 10.1006/viro.1994.1423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1423</ArticleId><ArticleId IdType="pubmed">8030260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauber C, Gorbalenya AE. Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses. J. Virol. 2012;86:3905â3915. doi: 10.1128/JVI.07174-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.07174-11</ArticleId><ArticleId IdType="pmc">PMC3302533</ArticleId><ArticleId IdType="pubmed">22278238</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, J. et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015. Emerg. Infect. Dis.24, 432â442 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823341</ArticleId><ArticleId IdType="pubmed">29460747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J, et al. Changing epidemiology of hand, foot, and mouth disease in China, 2013-2019: a population-based study. Lancet Reg. Health West Pac. 2022;20:100370. doi: 10.1016/j.lanwpc.2021.100370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100370</ArticleId><ArticleId IdType="pmc">PMC8743221</ArticleId><ArticleId IdType="pubmed">35036978</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan LNT, et al. Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015â2018. PLoS Negl. Trop. Dis. 2020;14:e0008544. doi: 10.1371/journal.pntd.0008544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008544</ArticleId><ArticleId IdType="pmc">PMC7451980</ArticleId><ArticleId IdType="pubmed">32804980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, et al. Molecular surveillance of coxsackievirus A16 in southern China, 2008-2019. Arch. Virol. 2021;166:1653â1659. doi: 10.1007/s00705-021-05052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05052-8</ArticleId><ArticleId IdType="pubmed">33796884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr. Infect. Dis. J. 1999;18:1092â1096. doi: 10.1097/00006454-199912000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199912000-00013</ArticleId><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Legay F, et al. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg. Infect. Dis. 2007;13:1084â1086. doi: 10.3201/eid1307.070295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1307.070295</ArticleId><ArticleId IdType="pmc">PMC2878248</ArticleId><ArticleId IdType="pubmed">18214187</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Li L, Wu MH, Lee CY, Huang LM. Fatal coxsackievirus A16 infection. Pediatr. Infect. Dis. J. 2004;23:275â276. doi: 10.1097/01.inf.0000115950.63906.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000115950.63906.78</ArticleId><ArticleId IdType="pubmed">15014311</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, et al. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS ONE. 2014;9:e96051. doi: 10.1371/journal.pone.0096051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096051</ArticleId><ArticleId IdType="pmc">PMC4002479</ArticleId><ArticleId IdType="pubmed">24776922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum. Vaccin Immunother. 2014;10:360â367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS ONE. 2013;8:e82861. doi: 10.1371/journal.pone.0082861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082861</ArticleId><ArticleId IdType="pmc">PMC3858299</ArticleId><ArticleId IdType="pubmed">24340064</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E. Picornavirus morphogenesis. Microbiol. Mol. Biol. Rev. 2014;78:418â437. doi: 10.1128/MMBR.00012-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, et al. Immunological and biochemical characterization of coxsackie virus A16 viral particles. PLoS ONE. 2012;7:e49973. doi: 10.1371/journal.pone.0049973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049973</ArticleId><ArticleId IdType="pmc">PMC3511423</ArticleId><ArticleId IdType="pubmed">23226233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Structures of Coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicity. J. Virol. 2015;89:10500â10511. doi: 10.1128/JVI.01102-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01102-15</ArticleId><ArticleId IdType="pmc">PMC4580203</ArticleId><ArticleId IdType="pubmed">26269176</ArticleId></ArticleIdList></Reference><Reference><Citation>He M, et al. Identification of antibodies with non-overlapping neutralization sites that target Coxsackievirus A16. Cell Host Microbe. 2020;27:249â261.e245. doi: 10.1016/j.chom.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7539366</ArticleId><ArticleId IdType="pubmed">32027857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424â429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses. Cell Discov. 2019;5:4. doi: 10.1038/s41421-018-0073-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-018-0073-7</ArticleId><ArticleId IdType="pmc">PMC6331555</ArticleId><ArticleId IdType="pubmed">30652025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, et al. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nat. Microbiol. 2019;4:124â133. doi: 10.1038/s41564-018-0275-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0275-7</ArticleId><ArticleId IdType="pmc">PMC6727974</ArticleId><ArticleId IdType="pubmed">30397341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Hepatitis A virus and the origins of picornaviruses. Nature. 2015;517:85â88. doi: 10.1038/nature13806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13806</ArticleId><ArticleId IdType="pmc">PMC4773894</ArticleId><ArticleId IdType="pubmed">25327248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor. Emerg. Microbes Infect. 2017;6:e65. doi: 10.1038/emi.2017.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.55</ArticleId><ArticleId IdType="pmc">PMC5567171</ArticleId><ArticleId IdType="pubmed">28745308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 2012;86:5686â5696. doi: 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, C. et al. Beta-propiolactone inactivation of Coxsackievirus A16 induces structural alteration and surface modification of viral capsids. J. Virol.91, e00038-17 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5375664</ArticleId><ArticleId IdType="pubmed">28148783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 2013;4:1929. doi: 10.1038/ncomms2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2889</ArticleId><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner T, Radbruch A. Antibodies and B cell memory in viral immunity. Immunity. 2007;27:384â392. doi: 10.1016/j.immuni.2007.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.09.002</ArticleId><ArticleId IdType="pubmed">17892847</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine. 2012;30:6642â6648. doi: 10.1016/j.vaccine.2012.08.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.08.071</ArticleId><ArticleId IdType="pubmed">22959985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, et al. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine. 2013;31:2215â2221. doi: 10.1016/j.vaccine.2013.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.007</ArticleId><ArticleId IdType="pubmed">23499596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice. Antivir. Res. 2016;129:47â51. doi: 10.1016/j.antiviral.2016.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.02.011</ArticleId><ArticleId IdType="pubmed">26902108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Huang X, Liu Q, Huang Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine. 2013;31:2130â2136. doi: 10.1016/j.vaccine.2013.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.02.051</ArticleId><ArticleId IdType="pubmed">23499595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat. Commun. 2021;12:264. doi: 10.1038/s41467-020-20465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20465-w</ArticleId><ArticleId IdType="pmc">PMC7801428</ArticleId><ArticleId IdType="pubmed">33431876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, et al. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 2015;89:12084â12095. doi: 10.1128/JVI.02189-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 2013;87:3335â3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137â145. doi: 10.1016/S0962-8924(03)00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00005-9</ArticleId><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A, Valeiras M, Sidransky E, Tayebi N. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology. Mol. Genet. Metab. 2014;111:84â91. doi: 10.1016/j.ymgme.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3924958</ArticleId><ArticleId IdType="pubmed">24389070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler KL, et al. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:e1003240. doi: 10.1371/journal.ppat.1003240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003240</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, et al. Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10. Nat. Commun. 2020;11:38. doi: 10.1038/s41467-019-13936-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13936-2</ArticleId><ArticleId IdType="pmc">PMC6946704</ArticleId><ArticleId IdType="pubmed">31911601</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, et al. Interaction of the poliovirus receptor with poliovirus. Proc. Natl Acad. Sci. USA. 2000;97:79â84. doi: 10.1073/pnas.97.1.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.1.79</ArticleId><ArticleId IdType="pmc">PMC26619</ArticleId><ArticleId IdType="pubmed">10618374</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 2001;8:874â878. doi: 10.1038/nsb1001-874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb1001-874</ArticleId><ArticleId IdType="pmc">PMC4152846</ArticleId><ArticleId IdType="pubmed">11573093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, et al. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414â419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Du R, et al. A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge. Hum. Vaccin. Immunother. 2019;15:2343â2350. doi: 10.1080/21645515.2019.1565266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1565266</ArticleId><ArticleId IdType="pmc">PMC6816366</ArticleId><ArticleId IdType="pubmed">30735461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente JO, et al. Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J. Virol. 2013;87:7637â7645. doi: 10.1128/JVI.03519-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03519-12</ArticleId><ArticleId IdType="pmc">PMC3700288</ArticleId><ArticleId IdType="pubmed">23637404</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins GM, Rambaut A, Pybus OG, Holmes EC. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 2002;54:156â165. doi: 10.1007/s00239-001-0064-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-001-0064-3</ArticleId><ArticleId IdType="pubmed">11821909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Shi J, Liu Q, Huang Z. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. J. Virol. Methods. 2012;186:193â197. doi: 10.1016/j.jviromet.2012.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.06.025</ArticleId><ArticleId IdType="pubmed">22771741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Ma N, Madden TL, Ostell JM. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013;41:W34âW40. doi: 10.1093/nar/gkt382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt382</ArticleId><ArticleId IdType="pmc">PMC3692102</ArticleId><ArticleId IdType="pubmed">23671333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi, Y. et al. Identification of human Norovirus GII.3 blockade antibody epitopes. Viruses13, 2058 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8539815</ArticleId><ArticleId IdType="pubmed">34696487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, et al. Structural basis for recognition of human Enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody. PLoS Pathog. 2016;12:e1005454. doi: 10.1371/journal.ppat.1005454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005454</ArticleId><ArticleId IdType="pmc">PMC4777393</ArticleId><ArticleId IdType="pubmed">26938634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Nat. Commun. 2021;12:2904. doi: 10.1038/s41467-021-23199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23199-5</ArticleId><ArticleId IdType="pmc">PMC8131599</ArticleId><ArticleId IdType="pubmed">34006855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331â332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Leiro R, Scheres SHW. A pipeline approach to single-particle processing in RELION. Acta Crystallogr. D. Struct. Biol. 2017;73:496â502. doi: 10.1107/S2059798316019276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798316019276</ArticleId><ArticleId IdType="pmc">PMC5458491</ArticleId><ArticleId IdType="pubmed">28580911</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216â221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290â296. doi: 10.1038/nmeth.4169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4169</ArticleId><ArticleId IdType="pubmed">28165473</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal PB, Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 2003;333:721â745. doi: 10.1016/j.jmb.2003.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2003.07.013</ArticleId><ArticleId IdType="pubmed">14568533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Garcia R, et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 2021;4:874. doi: 10.1038/s42003-021-02399-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02399-1</ArticleId><ArticleId IdType="pmc">PMC8282847</ArticleId><ArticleId IdType="pubmed">34267316</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006;22:195â201. doi: 10.1093/bioinformatics/bti770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bti770</ArticleId><ArticleId IdType="pubmed">16301204</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMaio F, et al. Atomic-accuracy models from 4.5-A cryo-electron microscopy data with density-guided iterative local refinement. Nat. Methods. 2015;12:361â365. doi: 10.1038/nmeth.3286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3286</ArticleId><ArticleId IdType="pmc">PMC4382417</ArticleId><ArticleId IdType="pubmed">25707030</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. 2010;66:213â221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2004;60:2126â2132. doi: 10.1107/S0907444904019158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen VB, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:12â21. doi: 10.1107/S0907444909042073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909042073</ArticleId><ArticleId IdType="pmc">PMC2803126</ArticleId><ArticleId IdType="pubmed">20057044</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddard TD, Huang CC, Ferrin TE. Visualizing density maps with UCSF Chimera. J. Struct. Biol. 2007;157:281â287. doi: 10.1016/j.jsb.2006.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2006.06.010</ArticleId><ArticleId IdType="pubmed">16963278</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774â797. doi: 10.1016/j.jmb.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.022</ArticleId><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Rossmann MG. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 2007;158:182â187. doi: 10.1016/j.jsb.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2006.10.013</ArticleId><ArticleId IdType="pmc">PMC1978246</ArticleId><ArticleId IdType="pubmed">17116403</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlee S, et al. Prediction of quaternary structure by analysis of hot spot residues in protein-protein interfaces: the case of anthranilate phosphoribosyltransferases. Proteins. 2019;87:815â825. doi: 10.1002/prot.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25744</ArticleId><ArticleId IdType="pubmed">31134642</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>